Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

Carcinogenesis ◽

10.1093/carcin/17.12.2581 ◽

1996 ◽

Vol 17 (12) ◽

pp. 2581-2587 ◽

Author(s):

F. Farinati ◽

L. Herszènyi ◽

M. PIebani ◽

P. Carraro ◽

M. De Paoli ◽

...

Keyword(s):

Plasminogen Activator ◽

Cathepsin B ◽

Gastric Carcinogenesis ◽

Early Event ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

10.1186/1471-2407-8-194 ◽

2008 ◽

Vol 8 (1) ◽

Author(s):

László Herszényi ◽

Fabio Farinati ◽

Romilda Cardin ◽

Gábor István ◽

László D Molnár ◽

...

Keyword(s):

Plasminogen Activator ◽

Cathepsin B ◽

Cathepsin L ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer

Gastroenterology ◽

10.1016/s0016-5085(01)82981-4 ◽

2001 ◽

Vol 120 (5) ◽

pp. A599-A600 ◽

Author(s):

L HERSZENYI ◽

F FARINATI ◽

G ISTVAN ◽

M PAOLI ◽

G ROVERONI ◽

...

Keyword(s):

Colorectal Cancer ◽

Plasminogen Activator ◽

Plasma Levels ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.040 ◽

2004 ◽

Vol 5 (5) ◽

pp. 348-352 ◽

Author(s):

Nadia Harbeck ◽

Ronald E. Kates ◽

Manfred Schmitt ◽

Katja Gauger ◽

Marion Kiechle ◽

...

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Primary Breast Cancer ◽

Therapy Response ◽

Disease Outcome ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Download Full-text

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

Fibrinolysis and Proteolysis ◽

10.1016/0268-9499(94)90453-7 ◽

1994 ◽

Vol 8 ◽

pp. 61 ◽

Author(s):

B. Landau ◽

S. Brern ◽

E. Verrusio ◽

H. Kwaan

Keyword(s):

Brain Tumors ◽

Human Brain ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

92 Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

Fibrinolysis and Proteolysis ◽

10.1016/s0268-9499(96)80179-2 ◽

1996 ◽

Vol 10 ◽

pp. 30

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Single Chain ◽

Plasminogen Activator Inhibitor Type ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Type-1 mRNA Assessment in Breast Cancer by Means of NASBA

American Journal of Clinical Pathology ◽

10.1309/k4jaf2nmd5eju67y ◽

2007 ◽

Vol 128 (3) ◽

pp. 404-413 ◽

Author(s):

Pierre-Jean Lamy ◽

Thibault Verjat ◽

Anne-Claire Servanton ◽

Malik Paye ◽

Philippe Leissner ◽

...

Keyword(s):

Breast Cancer ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor Type ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Correlation between protein and RNA tissue concentration of invasion factors urokinase-type plasminogen activator (uPA) and its inhibitor, plasminongen activator inhibitor type 1 (PAI-1)

Zentralblatt für Gynäkologie ◽

10.1055/s-2005-921021 ◽

2005 ◽

Vol 127 (04) ◽

Author(s):

M Bader ◽

C Thomssen ◽

E Laczynska ◽

M Gehrmann ◽

M Munnes ◽

...

Keyword(s):

Plasminogen Activator ◽

Tissue Concentration ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor ◽

Download Full-text

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.11.025 ◽

2008 ◽

Vol 108 (3) ◽

pp. 569-576 ◽

Author(s):

E. Steiner ◽

K. Pollow ◽

D. Hasenclever ◽

W. Schormann ◽

M. Hermes ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor ◽

Download Full-text

479 Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 in human brain tumors primary cultures

Fibrinolysis and Proteolysis ◽

10.1016/s0268-9499(96)80565-0 ◽

1996 ◽

Vol 10 ◽

pp. 138

Keyword(s):

Brain Tumors ◽

Plasminogen Activator ◽

Primary Cultures ◽

Plasminogen Activator Inhibitor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type ◽

Activator Inhibitor

Download Full-text

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/93.12.913 ◽

2001 ◽

Vol 93 (12) ◽

pp. 913-920 ◽

Author(s):

F. Janicke ◽

A. Prechtl ◽

C. Thomssen ◽

N. Harbeck ◽

C. Meisner ◽

...

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Breast Cancer Patients ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibitor Type ◽

Activator Inhibitor Type

Download Full-text